Skip to main content

Schroder ISF Hlthcr Innovt

Schroder ISF Hlthcr Innovt is an equity fund managed by Schroders in the Sektor – Helse category.

About this fund

Schroder ISF Hlthcr Innovt is an equity fund run by Schroders, compared against the Sektor – Helse peer group.

On return so far this year measured in NOK as of 13.11.2026, it places 13 of 18 funds in the group.

Launched in 2019, it has 7 years behind it.

The manager-stated volatility is 13.7%.

It is measured against MSCI ACWI NR.

Manager
Schroders
Category
Sektor – Helse
Region
Global
Sector
Diversified
Style
Large Blend
SFDR
Article 8
ISIN
LU1983299246
Inception
2019-07-31
Benchmark
MSCI ACWI NR
AUM
196 m USD
Returns
YTD 4.0% · 1Y 8.2% · 3Y 5.8% · 5Y 3.7%

Portfolio managers

Actively managedEquityGlobal
YTD Return · NOK
+4,0 %from NAV
The class started 31.07.2019. 10 years does not exist yet; the figure above is since launch, annualised (as of 30.10.2026).
Calculated NOK return from USD · A (NOK Calculated)

Computed from NAV history (total return, NOK, to 16 Nov 2026)

Last NAV 16 Nov 2026Latest NAV is 18 days old
Returns by period · NOK · net
ann. 3Y+
+4,0 %
YTD
+8,2 %
1y
+5,8 %
3y, annualised
+3,7 %
5y, annualised
Fund size
195,6 mill. USD
Total fund AUM
SFDR
Article 8
Sustainability
Launched
Jul 2019
ISIN LU1983299246
BenchmarkMSCI ACWI NR
About the fund
The fund

The fund is an actively managed equity fund investing in healthcare and medical-related companies worldwide. It has a track record going back to 2019. The management company is Schroders Investment Management in London, an asset manager with roots in 1804 as a trading and finance business. It runs active strategies in equities, fixed income, multi-asset and private markets. Since 1 October 2026 Schroders has been wholly owned by Nuveen, part of the US TIAA group, and is no longer listed.

Investment philosophy

The mandate restricts the fund to companies that meet the manager's sustainability criteria. The benchmark is a global all-sector equity index (MSCI ACWI), not a healthcare index.

The managers

The fund is managed by John Bowler in London. He is Schroders' global sector specialist for healthcare, has been with the firm since 2003 and has managed the fund since 2019. He previously worked as a healthcare analyst and portfolio manager at firms including AXA Investment Managers and State Street Research & Management. He holds a PhD in biochemistry and physiology from the University of Manchester.

The portfolio

The portfolio holds more companies than comparable funds and has fluctuated less than they have. Companies such as Johnson & Johnson, AstraZeneca, Eli Lilly and Thermo Fisher Scientific have stayed in the portfolio over time.

FundTelligence description · 18/10/2026
Comparison basis: Ranked among 18 of 31 funds · 13 left out (5 share class outside the rule, 3 missing return, 1 return as of an earlier date, 1 history too short, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026

Portfolio managers

JO
Portfolio Manager
On the fund since Jul 31, 2019

Position in the peer group

Sector Health Care Equities · 31 funds in the peer group. The number ranked and the date are stated per period. 12 of them converted to NOK.

7 of 18 funds ranked on a calculated return

#13/ 18Year to date
+3.98% NOK
From NAV as of 16 Nov 2026

as of 13 Nov 2026 · Converted from USD to NOK

About the figures

13 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.

#16/ 221 year
+8.23% NOK
From NAV as of 16 Nov 2026

as of 13 Nov 2026 · Converted from USD to NOK

About the figures

9 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.

#16/ 223 years (ann.)
+5.76% NOK
From NAV as of 16 Nov 2026

as of 13 Nov 2026 · Converted from USD to NOK

About the figures

9 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.

#17/ 225 years (ann.)
+3.73% NOK
From NAV as of 16 Nov 2026

as of 13 Nov 2026 · Converted from USD to NOK

About the figures

9 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.

Comparison basis

Year to date

Comparison basis: Ranked among 18 of 31 funds · 13 left out (5 share class outside the rule, 3 missing return, 1 return as of an earlier date, 1 history too short, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026

1 year

Comparison basis: Ranked among 22 of 31 funds · 9 left out (4 missing return, 2 return as of an earlier date, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026

3 years (ann.)

Comparison basis: Ranked among 22 of 31 funds · 9 left out (4 missing return, 2 return as of an earlier date, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026

5 years (ann.)

Comparison basis: Ranked among 22 of 31 funds · 9 left out (4 missing return, 2 return as of an earlier date, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026

The positions describe historical return and are not an assessment of the fund, nor investment advice. Past performance is no guarantee of future returns. A position applies only within its own peer group and cannot be compared with positions in other peer groups.

Fund data is taken from the managers’ own reports, otherwise computed from NAV history and, as a last resort, taken from distributor listings. Not official figures; verify with the fund provider before investing.

About our data